Cardioloxía
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublications in collaboration with researchers from Hospital Universitari de Bellvitge (142)
2024
-
A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study
JACC: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 756-767
-
Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)
Journal of Clinical Medicine, Vol. 13, Núm. 9
-
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473
-
Impact of gender on in-hospital and long-term outcomes after transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry
Revista Espanola de Cardiologia
-
Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63
Scientific Reports, Vol. 14, Núm. 1
-
Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets
Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 1, pp. 90-97
-
Prevalence of Fabry disease in patients with left ventricular hypertrophy and renal involvement (PrEFaCe)
Medicina Clinica
-
Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial
Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460
-
Risk prediction of major cardiac adverse events and all-cause death following covid-19 hospitalization at one year follow-up: The HOPE-2 score
European Journal of Internal Medicine, Vol. 124, pp. 108-114
-
Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)
Revista Espanola de Cardiologia, Vol. 77, Núm. 11, pp. 936-946
2023
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
-
Cardiorenal benefits of finerenone: protecting kidney and heart
Annals of Medicine, Vol. 55, Núm. 1, pp. 502-513
-
Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19
Journal of Clinical Medicine, Vol. 12, Núm. 11
-
Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction
Journal of Clinical Medicine, Vol. 12, Núm. 8
-
Coronary angiography in patients without ST-segment elevation following out-of-hospital cardiac arrest. COUPE clinical trial
Revista Espanola de Cardiologia, Vol. 76, Núm. 2, pp. 94-102
-
Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses
European heart journal. Quality of care & clinical outcomes, Vol. 9, Núm. 2, pp. 194-202
-
Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry
ESC Heart Failure, Vol. 10, Núm. 5, pp. 2875-2881
-
Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain
Journal of Clinical Medicine, Vol. 12, Núm. 16
-
Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry
ESC Heart Failure, Vol. 10, Núm. 2, pp. 1193-1204
-
Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat
Patient Preference and Adherence, Vol. 17, pp. 839-849